Heng Liu
Fortuna: 180 M $ al 30/09/2026
Fortuna: 180 M $ al 30/09/2026
Dr. Heng Liu is a Chairman & General Manager at LongBio Pharma (Suzhou) Co., Ltd. Dr. Liu was previously employed as a Deputy Director-Pre Clinical Research by Evive Biotechnology (Shanghai Ltd. and a Co-Founder by Pharmab, Inc. He received his undergraduate degree from Shenyang Pharmaceutical University and a doctorate degree from The State University of New York.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
17,78 % | 06/07/2026 | 13.347.056 ( 17,78 % ) | 180 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.